BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

Synergy Partners


Contact Details:
One Broadway Suite 600
Cambridge
MA
02142
United States of America
Tel:617 621 1557
Fax:
Email:

Loading...

BioNews Results for Synergy Partners:

Cyclacel Publishes Study of Seliciclib Synergy with Tarceva and Herceptin in Journal Clinical Cancer Research
Earthtimes.org:  Jul 14 2008 11:15AM Matching: synergy partners
Cyclacel Publishes Study of Seliciclib Synergy with Tarceva and Herceptin in Journal Clinical Cancer Research
Pharma Live:  Jul 14 2008 4:11PM Matching: synergy partners
Cyclacel Publishes Study of Seliciclib Synergy with Tarceva and Herceptin in Journal Clinical Cancer Research
PR inside:  Jul 14 2008 11:37AM Matching: synergy partners

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 211 times since April 2007, the link to the organisation's website has been followed 0 times

Recent Search Terms used to find this page: synergy partners 617 | Synergy Partners | .

Search for more companies in Cambridge

Search for more companies in MA



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Synergy Partners
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.